We also anticipate from the observed HNSTD in NHP that the recommended therapeutic dose in humans will be sufficient to overcome the sink effect of normal nectin-4 expression while ensuring complete tumor penetration to maximize the cytotoxic effects of exatecan. Here, NECTIN4 is linked to neoplasm.